A carregar...
Escalation strategies for combination therapy Phase I trials
Phase I clinical trials aim to identify a maximum tolerated dose (MTD), the highest possible dose that does not cause an unacceptable amount of toxicity in the patients. In trials of combination therapies, however, many different dose combinations may have a similar probability of causing a dose-lim...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3573644/ https://ncbi.nlm.nih.gov/pubmed/22411472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.1497 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|